H.R. 5594 (107th): To amend the Federal Food, Drug, and Cosmetic Act to require labeling containing information applicable to pediatric patients.


Oct 9, 2002
107th Congress, 2001–2002

Died in a previous Congress

This bill was introduced on October 9, 2002, in a previous session of Congress, but was not enacted.


Constance Morella

Representative for Maryland's 8th congressional district



Read Text »
Last Updated: Oct 9, 2002
Length: 14 pages

About the bill

Summary (CRS)

Amends the Federal Food, Drug, and Cosmetic Act to require license applications for new drugs and biological products to assess such drug's or product's safety and effectiveness for relevant pediatric ... Read more >

The bill’s title was written by its sponsor.


Oct 9, 2002

This is the first step in the legislative process.

This is a House of Representatives bill in the United States Congress (indicated by the “H.R.” in “H.R. 5594”). A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.


1 cosponsors (1R) (show)
Committee Assignments

The committee chair determines whether a bill will move past the committee stage.


There have been no roll call votes related to this bill.

Links & tools

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Click a format for a citation suggestion: